
A radiation-free system for lung function monitoring
Although modern respirators present ever increasing features to enhance and simplify ventilation therapy, methods to quantify the efficacy of ventilator changes are limited.

Although modern respirators present ever increasing features to enhance and simplify ventilation therapy, methods to quantify the efficacy of ventilator changes are limited.

At the Annual Congress of the European Respiratory Society (ERS), which took place in Stockholm, September 15-19, 2007, researchers from the Imperial College London, UK, presented their study about the successful implantation of lung cells grown from embryonic stem cells into the lungs of mice. In future, this method could be used for the treatment of human lung diseases.

The Lifebridge B2T (bridge-to-transport) is the first, fully portable emergency life support system for patients suffering cardiogenic shock, or those showing signs of imminent cardiogenic shock.

Lung cancer has a high mortality: Despite prevention programms each year 1.3 million people die due to malignant mutation of lung cells. It's the most common cause of cancer-related death in men, second most common in women.

Magnetic resonance imaging (MRI) as a non-invasive diagnostic method has been evolving into an attractive alternative to methods associated with radiation exposure.

SpiroStar is the smallest lung function testing system in the world, reports its Finnish manufacturer Medikro Oy. Weighing just 22 grams, this also became one of the first to satisfy the new and changed requirements for the calculation of lung function testing, meeting the latest ATS/ERS spirometry standards.
syngo Lung CAD, the second generation of nodule detection software from Siemens received FDA approval letter.

After previous meetings in the USA (2002) and Japan (2004), this October the 3rd International Workshop of Pulmonary Functional Imaging (IWPFI) took place in the German Cancer Research Centre, based in Heidelberg University, Germany. " 'The clinicians' need for earlier and more detailed diagnosis in pulmonary disease demands a joint interdisciplinary effort to push the limits in pulmonary…

German medical technology firm Novalung GmbH (est. 2002) produces extracorporeal artificial lungs.

Lung cancer (pulmonary carcinoma) is one of the most common cancers worldwide and the leading cause of cancer-related deaths globally. The diagnostic and therapeutic options for lung cancer have expanded significantly in recent years. Keep reading for latest developments in screening, biomarker testing, treatment innovations, and ongoing research.